Abstract
In 1973, based on evidence yielded by morphine binding studies, Pert and Snyder first proposed that the pharmacologic actions of morphine are effected through a reversible binding of the opiate to specific receptors in the central nervous system (CNS). Subsequently, investigators reported several opiate receptor types (Martin et al, 1976; Lord et al, 1977); more recently, evidence for opiate receptor subtypes has also been presented (Pasternak, 1984). Despite these substantial advancements, however, surprisingly little is known concerning the cascade of biochemical events triggered by the binding of opiate alkaloids to receptor sites in the CNS (Miller, 1984). Most studies intended to elucidate the biochemical actions of opiates are primarily concerned with the effects of these compounds on the activities of the various enzymes involved in adenylate nucleoside metabolism (Palmer, 1983). The numerous contradictory reports in this line of research have, however, clearly demonstrated the futility of attempts to correlate opiate activity to brain levels of the adenylate cyclic nucleotide (Wollemann, 1981; Palmer, 1983). Similarly, there is little consensus regarding the effects of opiates on guanylate cyclic nucleotide concentrations, a subject on which comparatively few investigations have thus far been conducted (Palmer, 1983).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barankiewicz, J., and Cohen, A., 1984, Nucleotide catabolism and nucleoside cycles in human thymocytes. Role of orthophosphate, Biochem. J., 219: 197–203.
Cardenas, H. L., and Ross, D. H., 1975, Morphine induced calcium depletion in discrete regions of rat brain, J. Neurochem., 24: 487–493.
Cohn, M. L., Cohn, M., and Taylor, F. H., 1978, Cyclic GMP: a central nervous system regulator of analgesia, Science, 199: 319–322.
Cohn, M. L., Cohn, M., Larrinaga, J., Wooten, D. J., Samora, J., and Fernandez, G., 1983, Morphine: a new site of action in purine nucleoside pathways, Society for Neuroscience, 9: 89.
Cohn, M. L., Yakel, J., Samora, J., Larrinaga, J., Fernandez, G., and Wooten, D. J., 1984, Morphine and calcium channel blockers: effects on cGMP metabolism in rat brain, Society for Neuroscience, 10: 592.
Collier, H. O. J., and Roy, A. C., 1974, Hypothesis: inhibition of E prostaglandin-sensitive adenyl cyclase as the mechanism of morphine analgesia, Prostaglandins, 7: 361–373.
Ho, I. K., Loh, H. H., and Way, E. L., 1972, Effects of cyclic AMP on morphine analgesia, tolerance and physical dependence, Nature, 238: 397–398.
Lord, J. A., Waterfield, A. A., Hughes, J., and Kosterlitz, H. W., 1977, Endogenous opioid peptides: multiple agonists and receptors, Nature, 267: 495–499.
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., and Gilbert, P. E., 1976, The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther., 197: 517–532.
Miller, R., 1984, How do opiates act?, Trends NeuroSci., 7: 184–185.
Moreno, J., Cohn, M., Cohn, M. L., 1982, GMP reductase activity in rat brain slices, Minority Bioscience Symposium, 10: 161.
Palmer, G. C., 1983, Effects of psychoactive drugs on cyclic nucleotides in the central nervous system, in: “Progress in Neurobiology,” G. A. Kerkut and J. W. Phillis, ed., 21: 1–133.
Partington, C. R., Edwards, M. W., and Daly, J. W., 1980, Regulation of cyclic AMP formation in brain tissue by alpha-adrenergic receptors: requisite intermediacy of prostaglandins of the E series, Proc. Natl. Acad. Sci. USA, 77: 3024–3028.
Pasternak, G., 1984, The contribution of multiple-opiate receptors to spinal and supraspinal pain control, IVth World Congress on Pain, Seattle, Washington, August 31-September 5.
Pert, C. B., and Snyder, S. H., 1973, Opiate receptor: demonstration in nervous tissue, Science, 179: 1011–1014.
Spector, T., Jones, T. E., and Miller, R. L., 1979, Reaction mechanism and specificity of human GMP reductase. Substrates, inhibitors, activators, and inactivators, J. Biol. Chem., 254: 2308–2315.
Wollemann, M., 1981, Endogenous opioids and cyclic AMP, Prog. Neurobiol., 16: 145–154.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Cohn, M.L., Eggerding, F.A., Machado, A.F., Cohn, S.J., Waxman, B.D., Delaney, T. (1986). Morphine: Sites of Action in Guanosine Nucleoside Pathway. In: Nyhan, W.L., Thompson, L.F., Watts, R.W.E. (eds) Purine and Pyrimidine Metabolism in Man V. Advances in Experimental Medicine and Biology, vol 195B. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-1248-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1248-2_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-1250-5
Online ISBN: 978-1-4684-1248-2
eBook Packages: Springer Book Archive